Cellect Biotechnology

$1.94
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.03 (-1.57%) Today
+$0.06 (+3.19%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell APOP and other stocks, options, and ETFs commission-free!

About APOP

Cellect Biotechnology Ltd. engages in the provision of regenerative medicine. Its activities include development of regenerative medicine through the development of products facilitating immune stem cell selection. The company also develops innovative technology, which allows the default stem cells by dramatically reducing of complications existing in conventional selection methods. The company was founded by Kasbian Nuriel Chirich, Shai Yarkoni, and Nadir Askenasy on August 4, 1986 and is headquartered in Kfar Saba, Israel. The listed name for APOP is Cellect Biotechnology Ltd. American Depositary Shares.

CEO
Shai Yarkoni
Employees
14
Headquarters
Kfar Saba, Jerusalem
Founded
1986
Market Cap
7.35M
Price-Earnings Ratio
Dividend Yield
Average Volume
64.77K
High Today
$1.96
Low Today
$1.87
Open Price
$1.88
Volume
37.64K
52 Week High
$6.89
52 Week Low
$0.40

Collections

APOP Earnings

-$0.16
-$0.11
-$0.05
$0.00
Q4 FY18
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Estimated
per share
Actual
-$0.001 per share

You May Also Like